Skip to content
a16z News· Jorge Conde·· 2 h agoAI score58

a16z invests in Boltz as the startup closes a $110M Series A

Investing in Boltz

AI summary

a16z's Jorge Conde announced the firm is investing in Boltz, which has raised a $110M Series A for its molecular design models. Boltz's open-source models had reached every top 20 pharmaceutical company by the time a16z co-led its seed round last year, and weekly molecular token consumption by customers has risen roughly 50-fold in the last four months following the launches of BoltzMol-1 and BoltzProt-1. Boltz's commercial models are already deployed at Pfizer, GSK, Takeda and BMS, and the company charges for model usage while scientists retain ownership of what they create.

Source:a16z News · a16z.news